Atlas Trials

Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

Clinical trial NCT03977090 · UNKNOWN

Trial details

NCT number
NCT03977090
Sponsor
Genor Biopharma Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2019-04-04
Primary completion
2021-12-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.